(Total Views: 81)
Posted On: 03/14/2025 4:21:57 PM
Post# of 175
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q4 and Full-Year 2024 Financial Results, Highlights FDA Clearance and Commercial Progress
HeartBeam (NASDAQ: BEAT), a medical technology company focused on advanced cardiac care, announced its financial and operational results for the fourth quarter and full-year 2024. The company achieved key milestones, including FDA 510(k) clearance for the HeartBeam System, the launch of an Early Access Program to refine its clinical workflow, and the submission of an FDA application for its 12-lead ECG synthesis software. HeartBeam also raised $11.5 million in gross proceeds from a public offering to support commercialization efforts. Financially, research and development expenses rose to $11.1 million in 2024 from $6.8 million in 2023, while net loss widened to $19.4 million from $14.6 million year over year. The company closed 2024 with $2.4 million in cash and cash equivalents.
NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://nnw.fm/BEAT
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
HeartBeam (NASDAQ: BEAT), a medical technology company focused on advanced cardiac care, announced its financial and operational results for the fourth quarter and full-year 2024. The company achieved key milestones, including FDA 510(k) clearance for the HeartBeam System, the launch of an Early Access Program to refine its clinical workflow, and the submission of an FDA application for its 12-lead ECG synthesis software. HeartBeam also raised $11.5 million in gross proceeds from a public offering to support commercialization efforts. Financially, research and development expenses rose to $11.1 million in 2024 from $6.8 million in 2023, while net loss widened to $19.4 million from $14.6 million year over year. The company closed 2024 with $2.4 million in cash and cash equivalents.
NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://nnw.fm/BEAT
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)
